Aleta Biotherapeutics Company
Aleta Biotherapeutics focuses on transforming cellular therapeutics to allow a broader spectrum of cancer indications to be targeted.
Technology:
CAR-T therapy
Industry:
Private
Headquarters:
Natick, Massachusetts, United States
Founded Date:
2015-01-01
Employees Number:
11-50
Funding Status:
Early Stage Venture
Investors Number:
1
Total Funding:
13717679
Estimated Revenue:
$1M to $10M
Last Funding Date:
2021-07-16
Last Funding Type:
Series A
Register and Claim Ownership